Graves Disease After Thyroid Hormone Treatment for Thyroid Nodule

被引：0

作者：

Lai, Yun-Ju ^{[1
]}

Lin, Shih-Yi ^{[1
]}

Sheu, Wayne Huey-Herng ^{[1
]}

Lee, I-Te ^{[1
]}

机构：

[1] Taichung Vet Gen Hosp, Div Endocrinol & Metab, Dept Internal Med, Taichung 407, Taiwan

来源：

ENDOCRINOLOGIST | 2009年 / 19卷 / 02期

关键词：

Graves disease; nodular goiter; radioactive iodine uptake; thyrotoxicosis; thyroxin suppressive therapy; SUPPRESSIVE THERAPY; THYROXINE; IODINE; RECOGNITION; MANAGEMENT;

D O I：

10.1097/TEN.0b013e318198bb25

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Nodularity of the thyroid bland is extremely common, and suppression of thyroid-stimulating hormone secretion by thyroxin is one of the treatment options most often employed. However, exogenous thyroid hormone could be a precipitating factor for autoimmune hyperthyroidism. We studied a 39-year-old woman for a thyroid nodule found by sonogram. She had no palpable mass in the thyroid gland. She had no tremor. Thyroid function tests were normal. After 4 weeks of thyroxin 0.1-mg daily treatment. Graves disease was diagnosed by thyrotoxicosis and combined with diffuse increased radioactive iodine uptake in thyroid gland. The thyroxin was discontinued and the symptoms of thyrotoxicosis improved. Thyroid function test returned to normal, Physicians should be aware of the possibility of precipitating autoimmune hyperthyroidism with thyroxine suppressive therapy for thyroid nodules.

引用

页码：73 / 74

页数：2